Cargando…
Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator
A positive response in reversibility testing is widely used to diagnose patients with airway limitations. However, despite its simple procedure, it doesn’t accurately reflect the exact airway irreversibility. This study aimed to investigate the efficacy of a bronchodilation reversibility test using...
Autores principales: | Ahmed, Mona Ibrahim, Ahmed, Randa Ibrahim, Osama, Hasnaa, Khalifa, Amira Karam, Alshehri, Abdullah Ali, El-Saber Batiha, Gaber, Negm, Walaa A, Kamal, Marwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563321/ https://www.ncbi.nlm.nih.gov/pubmed/37814253 http://dx.doi.org/10.1186/s12890-023-02682-3 |
Ejemplares similares
-
Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
por: Balint, Beatrix, et al.
Publicado: (2010) -
Daily Use of Salmeterol Causes Tolerance to Bronchodilation with Terbutaline in Asthmatic Subjects
por: Elers, Jimmi, et al.
Publicado: (2010) -
Bronchodilator response after two methods of salbutamol nebulization in asthmatic children
por: Emeryk, Andrzej, et al.
Publicado: (2022) -
The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019) -
Small airway bronchodilator response to different doses of salbutamol in 7-year-old children
por: Yon, Dong Keon, et al.
Publicado: (2017)